26 results
8-K
EX-1.1
VERV
Verve Therapeutics Inc
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
are consummated or this Agreement is terminated, the Company will pay or cause to be paid all costs and expenses incident to the performance of its … obligations hereunder, including without limitation, (i) the costs incident to the authorization, issuance, sale, preparation and delivery of the Shares
8-K
EX-1.1
a2xxdi ept5s
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
S-3
EX-1.2
dzxxofbv2ta 07wf1t81
1 Jul 22
Shelf registration
4:36pm
10-K
jas16j
14 Mar 22
Annual report
7:04am
10-Q
nkd8a800 7l
12 Aug 21
Quarterly report
8:53am
8-K
EX-3.2
97i1w6ey
21 Jun 21
Amendments to Articles of Incorporation or Bylaws
5:06pm
424B4
bpyqvsqj67 srb
17 Jun 21
Prospectus supplement with pricing info
4:50pm
S-1/A
EX-1.1
hjhkscwqvf3rk
14 Jun 21
IPO registration (amended)
6:15am
S-1/A
rc3b7o4vst2 5tm7
14 Jun 21
IPO registration (amended)
6:15am
S-1
zkuaw3jv
28 May 21
IPO registration
4:04pm